Application (Glaucoma, Retinal Tear, Diabetes)
The diabetes segment is estimated to hold 45% share of the global ophthalmoscope market in the coming years owing to the increasing cases of diabetes-induced blindness around the world. Patients suffering from diabetes have affected retina which can lead to blindness. This as a result rises the demand for ophthalmoscopes as it helps in the on-time detection and diagnosis of the disease. As per recent reports, diabetic retinopathy is accountable for nearly 4.5 % of blindness cases across the globe. By 2030, there will be around 640 million diabetics worldwide, and by 2045, the figure is expected to rise to over 78o million.
End- Users (Hospitals, Eye Clinics)
Ophthalmoscope market from the hospital segment is set to garner a notable gain in the near future. The growth of the segment is driven by the rising usage of ophthalmoscopes. Owing to the growing awareness of eye-related diseases more and more people are visiting hospitals that offer ophthalmic services to seek timely diagnosis and help in the management of eye-related conditions. This, as a result, has increased the demand for ophthalmoscopes on the hospital premises.
Our in-depth analysis of the global market includes the following segments:
By End-User |
|
By Application |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?